- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Study Finds No Difference Between Avastin and Lucentis in Treatment of AMD

Posted By Dr. Ari Weitzner On October 8, 2010 @ 11:50 pm In Macular Degeneration,Research,Retina | Comments Disabled

Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System recently announced the results of a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD). The study, which appears currently on-line inĀ Eye, is believed to be the first study to describe one-year outcomes of a prospective, double-masked, randomized clinical trial directly comparing Avastin and Lucentis. Last October, these same researchers published early, six month outcomes of the same study, which also failed to show a difference in efficacy between these two drugs for treating AMD.

Read the full press release here [1].

For interested readers, Irv Arons is keeping track of the results of Avastin vs. Lucentis studies on his blog [2].


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/003482-study-finds-no-difference-between-avastin-and-lucentis-in-treatment-of-amd/

URLs in this post:

[1] here: http://www.eurekalert.org/pub_releases/2010-10/bumc-rfn092910.php

[2] blog: http://irvaronsjournal.blogspot.com/2010/10/avastinlucentis-update-42-one-year.html

Copyright © 2008 Eye Doc Talk. All rights reserved.